Gilder, Gagnon, Howe & Co »

Bridgebio Pharma shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 45k 30.92
2023-12-31 $1.6M 40k 40.37
2023-09-30 $1.1M 40k 26.37
2023-06-30 $612k 36k 17.20
2023-03-31 $528k 32k 16.58
2022-12-31 $248k 33k 7.62
2022-09-30 $481k 48k 9.94
2022-06-30 $443k 49k 9.09
2022-03-31 $8.6M 845k 10.15
2021-12-31 $14M 845k 16.68
2021-09-30 $35M 755k 46.87
2021-06-30 $46M 758k 60.96
2021-03-31 $47M 765k 61.60